UY34080A - Composición farmacéutica para administración oral que comprende fexofenadina y métodos de preparación - Google Patents

Composición farmacéutica para administración oral que comprende fexofenadina y métodos de preparación

Info

Publication number
UY34080A
UY34080A UY0001034080A UY34080A UY34080A UY 34080 A UY34080 A UY 34080A UY 0001034080 A UY0001034080 A UY 0001034080A UY 34080 A UY34080 A UY 34080A UY 34080 A UY34080 A UY 34080A
Authority
UY
Uruguay
Prior art keywords
pharmaceutical composition
oral administration
preparation methods
fexofenadine
includes fexofenadine
Prior art date
Application number
UY0001034080A
Other languages
English (en)
Inventor
Badabhagni Sudhakara Rao
Nilesh Jaiswal
Praveen Khullar
K U M Prasad
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of UY34080A publication Critical patent/UY34080A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención se refiere a una formulación farmacéutica de hidrocloruro de fexofenadina en un sistema de disolvente adecuada como una composición líquida de relleno. En otro aspecto, la invención también se refiere a un proceso para la preparación de dicha formulación farmacéutica y al uso de dicha composición para la preparación de un fármaco para el tratamiento de reacciones alérgicas en un paciente.
UY0001034080A 2011-05-20 2012-05-18 Composición farmacéutica para administración oral que comprende fexofenadina y métodos de preparación UY34080A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1727CH2011 2011-05-20
US201161499856P 2011-06-22 2011-06-22
EP11305923 2011-07-13

Publications (1)

Publication Number Publication Date
UY34080A true UY34080A (es) 2013-01-03

Family

ID=47216626

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034080A UY34080A (es) 2011-05-20 2012-05-18 Composición farmacéutica para administración oral que comprende fexofenadina y métodos de preparación

Country Status (18)

Country Link
US (1) US20140073670A1 (es)
EP (1) EP2709600A1 (es)
JP (1) JP2014513708A (es)
KR (1) KR20140037876A (es)
CN (1) CN103687592A (es)
AR (1) AR086491A1 (es)
BR (1) BR112013029778A2 (es)
CA (1) CA2835912A1 (es)
CO (1) CO6831986A2 (es)
CR (1) CR20130591A (es)
EA (1) EA201391742A1 (es)
EC (1) ECSP13013095A (es)
IL (1) IL229417A0 (es)
MA (1) MA35400B1 (es)
MX (1) MX2013013575A (es)
SG (1) SG195015A1 (es)
UY (1) UY34080A (es)
WO (1) WO2012159960A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015003109A1 (en) * 2013-07-03 2015-01-08 R.P. Scherer Technologies, Llc Capsule formulation comprising fexofenadine
US9504656B2 (en) * 2013-10-21 2016-11-29 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients
CN104133014B (zh) * 2014-07-16 2015-09-16 广州法尔麦兰药物技术有限公司 一种考察布洛伪麻缓释制剂释放度的方法
CN107847496A (zh) * 2015-02-20 2018-03-27 英仕柏集团有限责任公司 含有非索非那丁的软明胶胶囊

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929605A (en) 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
US6316473B1 (en) * 1997-04-11 2001-11-13 Fujisawa Pharmaceutical Co., Ltd. Two surfactant-containing medicinal composition
ID24463A (id) 1997-08-14 2000-07-20 Hoechst Marion Roussel Inc Metode meningkatkan ketersediaan hayati feksofenadin dan turunan-turunannya
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU2001244610A1 (en) * 2000-04-05 2001-10-23 Shionogi And Co., Ltd. Oil-in-water microemulsions containing tricyclic compounds or preconcentrates thereof
OA12619A (en) * 2001-06-21 2006-06-12 Pfizer Prod Inc Self-emulsifying formulations of cholesteryl estertransfer protein inhibitors.
EP1455753A1 (en) * 2001-12-20 2004-09-15 Bernard Charles Sherman Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
GB2391473B (en) * 2002-08-02 2004-07-07 Satishchandra Punambhai Patel Pharmaceutical compositions
CA2524773C (en) * 2003-05-08 2014-04-08 Nektar Therapeutics Uk Ltd Particulate coformulations of active substances with excipients
JP2005075804A (ja) * 2003-09-03 2005-03-24 Toyo Capsule Kk メナテトレノン含有医薬組成物
WO2005062722A2 (en) * 2003-11-21 2005-07-14 Sun Pharmaceutical Industries Limited Fexofenadine containing pharmaceutical formulation

Also Published As

Publication number Publication date
CO6831986A2 (es) 2014-01-10
JP2014513708A (ja) 2014-06-05
AR086491A1 (es) 2013-12-18
BR112013029778A2 (pt) 2017-01-17
MA35400B1 (fr) 2014-09-01
WO2012159960A1 (en) 2012-11-29
MX2013013575A (es) 2014-09-15
CN103687592A (zh) 2014-03-26
KR20140037876A (ko) 2014-03-27
US20140073670A1 (en) 2014-03-13
EA201391742A1 (ru) 2014-04-30
CR20130591A (es) 2014-05-07
CA2835912A1 (en) 2012-11-29
SG195015A1 (en) 2013-12-30
IL229417A0 (en) 2014-01-30
EP2709600A1 (en) 2014-03-26
ECSP13013095A (es) 2014-01-31

Similar Documents

Publication Publication Date Title
BR112013018877A2 (pt) composições farmacêuticas que compreendem anticorpos humanos para pcsk9
EP2747563A4 (en) COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION OF MEDICINAL PRODUCTS
UY33370A (es) Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización
BR112013017169A2 (pt) composições farmacêuticas de ferro para administração oral
EA201390804A1 (ru) Лекарственная форма лакозамида для приема один раз в сутки
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
EA201301240A1 (ru) Полиморфная форма бензоата линаглиптина
CL2012002424A1 (es) Método para tratar artitris reumatoide que comprende administrar al paciente laquinimod y metotrexato por vía oral; composición farmacéutica que los comprende.
BR112015004936A2 (pt) composição farmacêutica revestida contendo regorafenib
BR112013012476A2 (pt) formulações farmacêuticas contendo corticosteróides para administração tópica
IL230463A0 (en) Benzamides, their preparation and pharmaceutical preparations containing them
EP2701700A4 (en) PHARMACEUTICAL THERAPY FOR INHIBITING CHEMOTHERAPY-INDUCED SIDE EFFECTS AND CORRESPONDING PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING METHOD AND KITS
CO6950486A2 (es) Solución para administración oral
BR112014009889A2 (pt) compostos dissubstituídos, compostos e composição farmacêutica
BRPI1007484A2 (pt) composição farmacêutica para administração oral
DK2815752T3 (da) Oral farmaceutisk sammensætning
CU24163B1 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
BR112014025907A2 (pt) Formulação farmacêutica disponível para administração por via oral adequada para manejo aprimorado de transtornos do movimento
CO7010828A2 (es) Preparación farmacéutica que comprende ߖciclodextrina sustituida
UY34931A (es) ?formulación compuesta para administración oral que comprende metformina y rosuvastatina?.
CO7111279A2 (es) Composiciones farmacéuticas orales estables de liberación inmediata que contienen prasugrel
IL239958A (en) A chewable oral preparation and process for preparing it
UY34080A (es) Composición farmacéutica para administración oral que comprende fexofenadina y métodos de preparación
SMT201600243B (it) Composizioni farmaceutiche comprendenti anakinra senza citrato
BR112013025626A2 (pt) composição farmacêutica contendo ciclobenzaprina adequada para administração intranasal e uso da mesma

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20201019